Kathleen has been with FDA for 20 years as a Chemist in the Southeast Regional Laboratory, an Investigator in Atlanta District and an Investigator and Drug Preapproval Manager in Cincinnati District.
March 18 - 21, 2014 - Cintas Center at Xavier University
Mullen joined Patheon in 2011 as Chief Executive Officer. Prior to joining Patheon, he served as CEO and President at Biogen Idec Inc. from 2003 to 2010, one of the world’s largest biotechnology companies.
Michael Davison has over 27 years of experience in the Pharmaceutical Industry, he is an analytical chemist by training and joined Pfizer in 1986.
Ms. Fionnuala Walsh, PhD has been Senior Vice President of Global Quality at Eli Lilly & Co. since July 2007.
Jaspreet Gill is the Vice President, Global Quality and Compliance in Corporate Quality for Baxter Healthcare. In this role she is responsible for design & deployment of the Baxter Global Quality system as well as assessment & monitoring of its effectiveness.
The PharmaLink conference seeks solutions to important and complicated issues by aligning with the strategic priorities of the Food & Drug Administration. We help participants create links to drive new thinking. The solutions might not be evident within our industry, so we explore beyond industry, beyond borders, and beyond comfort zones. Don’t miss this opportunity to join your colleagues and global regulators from around the world so you can make a meaningful difference for your organization and our industry. PharmaLink actively fosters engagement among all participants and regulators, so true opportunity for change can be identified.Learn More
Join us on March 20, 2014 at the FDA/Xavier PharmaLink Conference as James Mullen, CEO of Patheon shares his thoughts on how all players in the complex global supply chain have a vital and interdependent leadership role in ensuring our medicines are safe and effective for patients around the world. The evening event will be […]
As an industry we work to achieve quality products that are effective and safe for the patients we serve while meeting their intended use. Learn what is at the heart of CDER’s challenge to industry to measure the level of quality achieved, and how that information could be used. CDER will share their vision, goals, […]